The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells

Standard

The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells. / Schirdewahn, Thomas; Grabowski, Jan; Owusu Sekyere, Solomon; Bremer, Birgit; Wranke, Anika; Lunemann, Sebastian; Schlaphoff, Verena; Kirschner, Janina; Hardtke, Svenja; Manns, Michael Peter; Cornberg, Markus; Wedemeyer, Heiner; Suneetha, Pothakamuri Venkata.

In: J INFECT DIS, Vol. 215, No. 1, 01.01.2017, p. 139-149.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Schirdewahn, T, Grabowski, J, Owusu Sekyere, S, Bremer, B, Wranke, A, Lunemann, S, Schlaphoff, V, Kirschner, J, Hardtke, S, Manns, MP, Cornberg, M, Wedemeyer, H & Suneetha, PV 2017, 'The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells', J INFECT DIS, vol. 215, no. 1, pp. 139-149. https://doi.org/10.1093/infdis/jiw514

APA

Schirdewahn, T., Grabowski, J., Owusu Sekyere, S., Bremer, B., Wranke, A., Lunemann, S., Schlaphoff, V., Kirschner, J., Hardtke, S., Manns, M. P., Cornberg, M., Wedemeyer, H., & Suneetha, P. V. (2017). The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells. J INFECT DIS, 215(1), 139-149. https://doi.org/10.1093/infdis/jiw514

Vancouver

Bibtex

@article{0854a41bb2fe46e19f5200dee55c9ce5,
title = "The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells",
abstract = "BACKGROUND:  Hepatitis D virus (HDV) infection affects 15-20 million individuals worldwide and causes severely progressive hepatitis. It is unknown to what extent cellular immune responses contribute to liver disease and control of viral replication in HDV infection.METHODS:  Immune cell frequencies and phenotypes were determined in 49 HDV-infected patients, 25 individuals with hepatitis B virus monoinfection and 18 healthy controls. T-cell proliferative and cytokine-producing capacities were analyzed by stimulation with overlapping peptides spanning the large HDV antigen. To restore T-cell responses, blocking antibodies (anti-cytotoxic T-lymphocyte antigen 4, anti-programmed death ligand 1) or proinflammatory cytokines (interleukin [IL] 12) were used.RESULTS:  Immune cell frequencies and phenotypes did not vary between the groups. Exclusively, the senescence marker CD57 was significantly up-regulated in CD8+ T cells from patients with hepatitis delta. HDV-specific T-cell proliferation and cytokine production were weak and could only partly be rescued by blockade of the programmed death 1 pathway. However, a more robust and consistent increase in HDV-specific CD4+ and CD8+ T-cell responses was evident when the third signal cytokine IL-12 was added, which also affected cytomegalovirus- and Epstein-Barr virus-specific T cells.CONCLUSIONS:  This investigation of virus-specific T-cell immunity in patients with HDV infection, the largest to date, revealed premature aging of immune cells and impaired T-cell functionality. This could be restored by blocking inhibitory pathways and, in particular, by supplementing with IL-12.",
keywords = "Adult, Aged, CD4-Positive T-Lymphocytes/immunology, CD57 Antigens/immunology, CD8-Positive T-Lymphocytes/immunology, CTLA-4 Antigen/immunology, Cytokines/biosynthesis, Cytomegalovirus/immunology, Female, Hepatitis D, Chronic/immunology, Hepatitis Delta Virus/chemistry, Herpesvirus 4, Human/immunology, Humans, Interleukin-12/administration & dosage, Lymphocyte Activation, Male, Middle Aged, Programmed Cell Death 1 Receptor/immunology, T-Box Domain Proteins/metabolism, Virus Replication",
author = "Thomas Schirdewahn and Jan Grabowski and {Owusu Sekyere}, Solomon and Birgit Bremer and Anika Wranke and Sebastian Lunemann and Verena Schlaphoff and Janina Kirschner and Svenja Hardtke and Manns, {Michael Peter} and Markus Cornberg and Heiner Wedemeyer and Suneetha, {Pothakamuri Venkata}",
note = "{\textcopyright} The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.",
year = "2017",
month = jan,
day = "1",
doi = "10.1093/infdis/jiw514",
language = "English",
volume = "215",
pages = "139--149",
journal = "J INFECT DIS",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

RIS

TY - JOUR

T1 - The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells

AU - Schirdewahn, Thomas

AU - Grabowski, Jan

AU - Owusu Sekyere, Solomon

AU - Bremer, Birgit

AU - Wranke, Anika

AU - Lunemann, Sebastian

AU - Schlaphoff, Verena

AU - Kirschner, Janina

AU - Hardtke, Svenja

AU - Manns, Michael Peter

AU - Cornberg, Markus

AU - Wedemeyer, Heiner

AU - Suneetha, Pothakamuri Venkata

N1 - © The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - BACKGROUND:  Hepatitis D virus (HDV) infection affects 15-20 million individuals worldwide and causes severely progressive hepatitis. It is unknown to what extent cellular immune responses contribute to liver disease and control of viral replication in HDV infection.METHODS:  Immune cell frequencies and phenotypes were determined in 49 HDV-infected patients, 25 individuals with hepatitis B virus monoinfection and 18 healthy controls. T-cell proliferative and cytokine-producing capacities were analyzed by stimulation with overlapping peptides spanning the large HDV antigen. To restore T-cell responses, blocking antibodies (anti-cytotoxic T-lymphocyte antigen 4, anti-programmed death ligand 1) or proinflammatory cytokines (interleukin [IL] 12) were used.RESULTS:  Immune cell frequencies and phenotypes did not vary between the groups. Exclusively, the senescence marker CD57 was significantly up-regulated in CD8+ T cells from patients with hepatitis delta. HDV-specific T-cell proliferation and cytokine production were weak and could only partly be rescued by blockade of the programmed death 1 pathway. However, a more robust and consistent increase in HDV-specific CD4+ and CD8+ T-cell responses was evident when the third signal cytokine IL-12 was added, which also affected cytomegalovirus- and Epstein-Barr virus-specific T cells.CONCLUSIONS:  This investigation of virus-specific T-cell immunity in patients with HDV infection, the largest to date, revealed premature aging of immune cells and impaired T-cell functionality. This could be restored by blocking inhibitory pathways and, in particular, by supplementing with IL-12.

AB - BACKGROUND:  Hepatitis D virus (HDV) infection affects 15-20 million individuals worldwide and causes severely progressive hepatitis. It is unknown to what extent cellular immune responses contribute to liver disease and control of viral replication in HDV infection.METHODS:  Immune cell frequencies and phenotypes were determined in 49 HDV-infected patients, 25 individuals with hepatitis B virus monoinfection and 18 healthy controls. T-cell proliferative and cytokine-producing capacities were analyzed by stimulation with overlapping peptides spanning the large HDV antigen. To restore T-cell responses, blocking antibodies (anti-cytotoxic T-lymphocyte antigen 4, anti-programmed death ligand 1) or proinflammatory cytokines (interleukin [IL] 12) were used.RESULTS:  Immune cell frequencies and phenotypes did not vary between the groups. Exclusively, the senescence marker CD57 was significantly up-regulated in CD8+ T cells from patients with hepatitis delta. HDV-specific T-cell proliferation and cytokine production were weak and could only partly be rescued by blockade of the programmed death 1 pathway. However, a more robust and consistent increase in HDV-specific CD4+ and CD8+ T-cell responses was evident when the third signal cytokine IL-12 was added, which also affected cytomegalovirus- and Epstein-Barr virus-specific T cells.CONCLUSIONS:  This investigation of virus-specific T-cell immunity in patients with HDV infection, the largest to date, revealed premature aging of immune cells and impaired T-cell functionality. This could be restored by blocking inhibitory pathways and, in particular, by supplementing with IL-12.

KW - Adult

KW - Aged

KW - CD4-Positive T-Lymphocytes/immunology

KW - CD57 Antigens/immunology

KW - CD8-Positive T-Lymphocytes/immunology

KW - CTLA-4 Antigen/immunology

KW - Cytokines/biosynthesis

KW - Cytomegalovirus/immunology

KW - Female

KW - Hepatitis D, Chronic/immunology

KW - Hepatitis Delta Virus/chemistry

KW - Herpesvirus 4, Human/immunology

KW - Humans

KW - Interleukin-12/administration & dosage

KW - Lymphocyte Activation

KW - Male

KW - Middle Aged

KW - Programmed Cell Death 1 Receptor/immunology

KW - T-Box Domain Proteins/metabolism

KW - Virus Replication

U2 - 10.1093/infdis/jiw514

DO - 10.1093/infdis/jiw514

M3 - SCORING: Journal article

C2 - 27803174

VL - 215

SP - 139

EP - 149

JO - J INFECT DIS

JF - J INFECT DIS

SN - 0022-1899

IS - 1

ER -